Skip to main content
. Author manuscript; available in PMC: 2016 Aug 26.
Published in final edited form as: Vaccine. 2011 Oct 5;29(52):9691–9696. doi: 10.1016/j.vaccine.2011.09.108

Fig. 1.

Fig. 1

CD1 mouse pathogenesis. Groups of 10-15 newborn mice were infected by intracranial injection with increasing doses of MVA, NYVAC, NYCBH, and NYCBHΔE3L or were mock infected with TBS. Percent survival was determined after 14 days.